Abstract: A display device includes a substrate including a display area including pixels and a non-display area around the display area and including a pad area, and a circuit board attached to the pad area. Pad electrodes arranged along a first direction and a first alignment mark located at a side of the pad electrodes in the first direction and protruding more than the pad electrodes are disposed on the substrate in the pad area. The circuit board includes a base portion, and lead electrodes disposed on the base portion and respectively facing the pad electrodes. A first alignment mark hole is defined through the base portion at a side of the lead electrodes in the first direction, the first alignment mark and the first alignment mark hole have a same shape as each other, and the first alignment mark is accommodated in the first alignment mark hole.

Abstract: The present disclosure relates to a composition for skin improvement and a pharmaceutical composition for preventing or treating an inflammatory skin disease, the compositions including an umbilical cord-derived mesenchymal stem cell culture medium as an active ingredient. The compositions exhibit a wound relief, wrinkle improvement, regeneration, elasticity increase, moisturizing, barrier strengthening, anti-inflammatory or antioxidant effect, and thus can be effectively used as a cosmetic composition for skin improvement or a pharmaceutical composition for preventing or treating an inflammatory skin disease.

Abstract: A payment terminal monitoring device includes: a communication unit which receives payment information generated in a payment terminal for each store; a detecting unit which detects status information of the payment terminal for each store; and a situation analyzing unit which classifies a store situation for each category, based on the payment information for each store, store information, and the status information and determines a store risk level.

Abstract: A payment terminal monitoring device includes: a communication unit which receives payment information generated in a payment terminal for each store; a detecting unit which detects status information of the payment terminal for each store; and a situation analyzing unit which classifies a store situation for each category, based on the payment information for each store, store information, and the status information and determines a store risk level.

Abstract: The present invention relates to a pharmaceutical composition including valsartan and rosuvastatin calcium as active ingredients, and a manufacturing method therefor. The pharmaceutical composition including valsartan and rosuvastatin calcium according to the present invention can alleviate side effects of the existing single preparations and simultaneously improve compliance of patients having a cardiovascular disease, a hyperlipidemic disease and a complex disease thereof, and increases treatment and prevention effects, and in particular, obtains synergistic effects in treating hyperlipidemia, and enhances the dissolution rate of valsartan and rosuvastatin calcium and treatment effects by granulating valsartan and mixing rosuvastatin calcium.

Abstract: The present invention relates to novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same.

Abstract: A system and method to manage a SET history of a simple network management protocol (SNMP), the system including an SNMP manager to access a network apparatus and to request an object ID, and an SNMP agent to set the object ID in response to the request and to transmit corresponding set information to a plurality of SNMP managers connected to a network so that a set history of the object ID can be stored and managed with respect to each SNMP manager.

Abstract: A method of charging printing costs using a printing charging system that is connected to an image forming apparatus, the method including: setting printing costs for each of a plurality of people; generating print data for each person, of the plurality of people, based on the set printing costs; and transmitting the generated print data to the image forming apparatus.

Abstract: An image forming device, a host device and a method of driving the same. The image forming device is connected to the host device through the network to perform a printing as requested by the host device and includes a light emitting unit and a controller. The light emitting unit emits a color light beam. The controller controls the host device to display a color mapped with the color of the light beam emitted from the light emitting unit during the printing. Thus, a user can easily know a position of the image forming device performing the printing and distinguish the printing processed by the image forming device, through the light beam emitted from the light emitting unit formed on an outer surface of the image forming device.

Abstract: The present invention relates to novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same.

Abstract: Novel compounds exhibiting good inhibitory activity versus Dipeptidyl Peptidase-IV(DPP-IV) include those of the following formula (1) or pharmaceutically acceptable salt thereof: wherein A is a substituted or unsubstituted 1,4,5,7-tetrahydro-pyrazolo[3,4-c]pyridine, 5,6 -dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazine, 4,5-dihydro-7H-isooxazolo[3,4-c]pyridine, 3,4 -dihydroisoquinoline, 5,8-dihydropyrido[3,4-d]pyrimidine, or 6,7 -dihydro[1,3]thiazolo[4,5,c]pyridine, and B is a substituted or unsubstituted piperidin-2-one, morpholin-3-one, oxazolidin-2-one, pyrrolidin-2-one, or 1,5-dihydro-pyrrol-2-one. Methods of preparing the novel inhibitory compounds of formula (1) and pharmaceutical compositions containing the same as an active agent are disclosed.

Abstract: A method of charging printing costs using a printing charging system that is connected to an image forming apparatus, the method including: setting printing costs for each of a plurality of people; generating print data for each person, of the plurality of people, based on the set printing costs; and transmitting the generated print data to the image forming apparatus.

Abstract: A printing device and a printing method using the same is disclosed. An air pocket is formed in a cliché stage to prevent a cleaning solution from permeating into a space between the cliché stage and a cliché plate, thereby preventing a lower surface of the cliché plate from being contaminated. The printing device comprises a cliché stage for fixation of a cliché plate, a plurality of vacuum holes disposed in the cliché stage for providing a vacuum to fix of the cliché plate to the cliché stage; and an air pocket surrounding the plurality of vacuum holes for providing air to minimize permeation of a cleaning solution into a space between the cliché plate and the cliché stage.

Abstract: The present invention relates to novel compounds exhibiting good inhibitory activity versus Dipeptidyl Peptidase-IV (DPP-IV), methods of preparing the same and pharmaceutical compositions containing the same as an active agent.

Abstract: A printing apparatus includes a rail, a printing plate and a substrate on the rail, the printing plate and the substrate being movable along the rail, a printing roll to transcribe a pattern material onto the substrate after passing through the printing plate on the rail, and a cleaning device to clean the printing plate, the cleaning device including at least one of a chemical knife and an air knife.

Abstract: An image forming device, a host device and a method of driving the same. The image forming device is connected to the host device through the network to perform a printing as requested by the host device and includes a light emitting unit and a controller. The light emitting unit emits a color light beam. The controller controls the host device to display a color mapped with the color of the light beam emitted from the light emitting unit during the printing. Thus, a user can easily know a position of the image forming device performing the printing and distinguish the printing processed by the image forming device, through the light beam emitted from the light emitting unit formed on an outer surface of the image forming device.

Abstract: A system and method to manage a SET history of a simple network management protocol (SNMP), the system including an SNMP manager to access a network apparatus and to request an object ID, and an SNMP agent to set the object ID in response to the request and to transmit corresponding set information to a plurality of SNMP managers connected to a network so that a set history of the object ID can be stored and managed with respect to each SNMP manager.

Abstract: The present invention relates to a novel cephalosporin compound, and pharmaceutically acceptable non-toxic salt, physiologically hydrolysable ester, hydrate, solvate or isomer thereof, to a pharmaceutical composition comprising the compound, and to a process for preparing the compound.

Abstract: The present invention relates to a novel cephalosporin compound in which thiomethylthio chain is introduced into C-3 position of cephem ring and pharmaceutically acceptable non-toxic salt, physiologically hydrolysable ester, hydrate, solvate or isomer thereof. The present invention also relates to a pharmaceutical composition containing the compound and to a process for preparing the compound.

Abstract: The present invention relates to a novel cephalosporin compound, and pharmaceutically acceptable non-toxic salt, physiologically hydrolysable ester, hydrate, solvate or isomer thereof, to a pharmaceutical composition containing the compound and to a process for preparing the compound.